NEW YORK ( TheStreet) -- Medivation (Nasdaq: MDVN) hit a new 52-week high Tuesday as it is currently trading at $96.44, above its previous 52-week high of $96.16 with 16,038 shares traded as of 9:39 a.m. ET. Average volume has been 730,400 shares over the past 30 days. Medivation has a market cap of $3.44 billion and is part of the health care sector and drugs industry. Shares are up 105.8% year to date as of the close of trading on Monday. Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!